Imaging ‐based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy

CONCLUSIONSChanges at the PDAC/parenchyma interface may serve as an early predictor of response to therapy. Cancer 2018. © 2018 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

Source: Cancer - January 25, 2018 Category: Cancer & Oncology Authors: Ahmed M. Amer, Mohamed Zaid, Baishali Chaudhury, Dalia Elganainy, Yeonju Lee, Christopher T. Wilke, Jordan Cloyd, Huamin Wang, Anirban Maitra, Robert A. Wolff, Gauri Varadhachary, Michael J. Overman, Jeffery E. Lee, Jason B. Fleming, Ching Wei Tzeng, Matt Tags: Original Article Source Type: research